Infusion of activated recombinant factor VII via an intra-pulmonary route by nebulizer or bronchoscopy has been shown to complete hemostasis and improve AH without adverse effects in SLE-AH patients [65, 66]. Here, F7 is linked to systemic lupus erythematosus.